Pancreatic Cancer Pipeline Report: Encapsulates all the Dormant and Discontinued Pipeline Projects
Mar 1, 2018
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer Pipeline Review, H2 2017, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.
Pune, India - March 1, 2018 /MarketersMedia/ —
Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Predisposing factors include age, gender, smoking, diabetes and family history. Treatment includes surgery, chemotherapy and radiation therapy.
Report Source: https://www.themarketreports.com/report/pancreatic-cancer-pipeline-review-h2-2017
Scope
• The pipeline guide provides a snapshot of the global therapeutic landscape of Pancreatic Cancer (Oncology).
• The pipeline guide reviews pipeline therapeutics for Pancreatic Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Pancreatic Cancer (Oncology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Pancreatic Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Pancreatic Cancer (Oncology)
Purchase this report at: https://www.themarketreports.com/report/buy-now/941654
Reasons To Buy
• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Pancreatic Cancer (Oncology).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Pancreatic Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/941654
Contact Info:
Name: Shirish Gupta
Email: [email protected]
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315
For more information, please visit https://www.themarketreports.com/report/pancreatic-cancer-pipeline-review-h2-2017
Source: MarketersMedia
Release ID: 307358
More News
Marissa Roy surges to early lead over John McKinney in L.A. city attorney race
Marissa Roy, 34, a deputy state attorney general, has campaigned on a promise to convert the city attorney's office into a massive "public interest law firm," while her opponent, veteran L.A. prosecutor John McKinney, has pitched himself as a more traditional law-and-order candidate.
Sheriff Luna leads challenger Villanueva in early returns; Measure A ahead
In a rematch of the 2022 race, L.A. County Sheriff Robert Luna has taken an early lead over Alex Villanueva, who is seeking to reclaim the office he held for a single term. A measure to establish binding arbitration for sheriff's deputies and other public safety employees is also on the ballot.
A measure to raise L.A.'s sales tax by a half-cent for firefighters leads in early returns
If approved, Measure FD on Tuesday's ballot would raise L.A.'s sales tax by 0.5% to boost funding for the Fire Department.
Barrera leads Shaw in early returns for state superintendent's race
Teachers union support — and a Democratic electorate — made Richard Barrera the favorite, even though Republican Sonja Shaw finished first in crowded primary.
It’s minutes to midnight: David Jones has run out of survival options
The biggest Black Friday sale this year could be David Jones itself after the department store operator’s last hope for a rescue deal collapsed.
Ugarte takes early lead for South L.A. City Council seat. San Fernando Valley race too close to call
Jose Ugarte led Estuardo Mazariegos in Council District 9, while Tim Gaspar and Barri Worth Girvan were nearly even, early returns show.
‘Cannon fodder’: Arson squad boss reveals firebombing toll on young offenders
After an arson attack on a Springvale factory, police say they are sick of urging youth not to accept jobs from crime bosses who consider them “expendable”.
Judge blasts 'slow' colleagues
Justice Ian Jackman of the Federal Court made headlines with a blistering speech.
Santa's second chance
Santa was seized following a high profile raid on a puppy farm in Canning Vale last Christmas. Now, he's living a life he once could have only dreamed of thanks to a Perth foster carer.
McLaren eyes big WA titanium resource boost after final assays
McLaren Minerals is set for a resource boost at its WA titanium project after final drilling assays delivered strong heavy mineral grades, including 21m at 6.35 per cent HM.
Frequently labelled as communists, who are the Democratic Socialists of America?
For years, the Democratic Socialists of America (DSA) had little influence over the machinery of the Democratic Party. That is beginning to change. The organisation has more than doubled its membership since 2024, reaching roughly 120,000, while growing numbers of DSA-backed candidates are positioning to expand its presence in Congress from two members to as many as seven. The breakthrough came in New York, where Zohran Mamdani’s victory in the 2025 mayoral race gave the movement its biggest...
Warning of cancelled, delayed Sydney bus services from industrial action
An escalating dispute over a new pay deal for thousands of drivers comes as the government unveiled an extra 3000 weekly bus services.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.